Abiopharma

RAND CAPITAL CORP (RAND) Reports the reporting period Financial Results RAND CAPITAL CORP (RAND) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 1075571
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: 330550
  • anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) evolving legal, regulatory and tax regimes; (2) changes in general economic and/or industry specific conditions; and (3) other risk factors as detailed from time to time in Rand’s reports filed with the Securities and Exchange Commission (“SEC”), including Rand’s annual report on Form 10-K for the year ended December 31, 2025